Catalyst Pharmaceuticals, Inc. (CPRX): Price and Financial Metrics

CPRX POWR Grades

• Quality is the dimension where CPRX ranks best; there it ranks ahead of 94.71% of US stocks.
• The strongest trend for CPRX is in Quality, which has been heading down over the past 178 days.
• CPRX ranks lowest in Stability; there it ranks in the 7th percentile.

CPRX Stock Summary

• The ratio of debt to operating expenses for CATALYST PHARMACEUTICALS INC is higher than it is for about only 9.98% of US stocks.
• Equity multiplier, or assets relative to shareholders' equity, comes in at 1.19 for CATALYST PHARMACEUTICALS INC; that's greater than it is for just 12.8% of US stocks.
• Over the past twelve months, CPRX has reported earnings growth of 98.83%, putting it ahead of 86.1% of US stocks in our set.
• If you're looking for stocks that are quantitatively similar to CATALYST PHARMACEUTICALS INC, a group of peers worth examining would be OSS, MOMO, CARG, CRTO, and PERI.
• Visit CPRX's SEC page to see the company's official filings. To visit the company's web site, go to www.catalystpharma.com.

CPRX Valuation Summary

• In comparison to the median Healthcare stock, CPRX's price/earnings ratio is 10.62% lower, now standing at 20.2.
• CPRX's price/sales ratio has moved NA NA over the prior 198 months.

Below are key valuation metrics over time for CPRX.

CPRX Growth Metrics

Its year over year cash and equivalents growth rate is now at 40.09%.
• Its 3 year price growth rate is now at 120.7%.
• The 2 year price growth rate now stands at 37.23%.

Over the past 33 months, CPRX's revenue has gone up $89,448,663.

The table below shows CPRX's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2022-09-30	191.755	95.146	66.917
2022-06-30	170.465	75.552	54.498
2022-03-31	153.717	65.036	45.06
2021-12-31	140.833	60.372	39.482
2021-09-30	133.5389	54.30157	41.61013
2021-06-30	126.9016	44.04568	74.621

CPRX's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• CPRX has a Quality Grade of B, ranking ahead of 86.8% of graded US stocks.
• CPRX's asset turnover comes in at 0.656 -- ranking 47th of 682 Pharmaceutical Products stocks.
• CHRS, XTNT, and BMY are the stocks whose asset turnover ratios are most correlated with CPRX.

The table below shows CPRX's key quality metrics over time.